Department of  Neurosurgery
Menu  -
»
Call Us: (314) 362-3636

Richard L. Price, MD, PhD

Richard L. Price, MDPosition: PGY 4
Hometown: Centerville, Ohio
Medical School: Ohio State University College of Medicine
Undergraduate: Ohio State University

Clinical/Research Interests: Glioblastoma, Oncolytic Viral therapy, virally-associated cancers

Hobbies: Traveling, Scuba diving, volleyball, cooking, movies

Grants:

  • J. William Fulbright Fellowship 2006-2007 (Madrid, Spain)
  • American Medical Association Seed Grant (2012)
Publications:

  • Evolution of malignant glioma treatment: from chemotherapy to vaccines to viruses. Price RL, Chiocca EA. Neurosurgery. 2014 Aug;61 Suppl 1:74-83. doi: 10.1227/NEU.0000000000000390. Review.
  • MicroRNA-128 coordinately targets Polycomb Repressor Complexes in glioma stem cells. Peruzzi P, Bronisz A, Nowicki MO, Wang Y, Ogawa D, Price R, Nakano I, Kwon CH, Hayes J, Lawler SE, Ostrowski MC, Chiocca EA, Godlewski J. Neuro Oncol. 2013 Sep;15(9):1212-24. doi: 10.1093/neuonc/not055. Epub 2013 Jun 3.
  • NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors. Alvarez-Breckenridge CA, Yu J, Price R, Wojton J, Pradarelli J, Mao H, Wei M, Wang Y, He S, Hardcastle J, Fernandez SA, Kaur B, Lawler SE, Vivier E, Mandelboim O, Moretta A, Caligiuri MA, Chiocca EA. Nat Med. 2012 Dec;18(12):1827-34. doi: 10.1038/nm.3013. Epub 2012 Nov 25.
  • The histone deacetylase inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells by inhibition of STAT5/T-BET signaling and generation of gamma interferon. Alvarez-Breckenridge CA, Yu J, Price R, Wei M, Wang Y, Nowicki MO, Ha YP, Bergin S, Hwang C, Fernandez SA, Kaur B, Caligiuri MA, Chiocca EA. J Virol. 2012 Apr;86(8):4566-77. doi: 10.1128/JVI.05545-11. Epub 2012 Feb 8.
  • Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutations. Price RL, Song J, Bingmer K, Kim TH, Yi JY, Nowicki MO, Mo X, Hollon T, Murnan E, Alvarez-Breckenridge C, Fernandez S, Kaur B, Rivera A, Oglesbee M, Cook C, Chiocca EA, Kwon CH. Cancer Res. 2013 Jun 1;73(11):3441-50. doi: 10.1158/0008-5472.CAN-12-3846.
  • Cytomegalovirus infection leads to pleomorphic rhabdomyosarcomas in Trp53+/- mice. Price RL, Bingmer K, Harkins L, Iwenofu OH, Kwon CH, Cook C, Pelloski C, Chiocca EA. Cancer Res. 2012 Nov 15;72(22):5669-74. doi: 10.1158/0008-5472.CAN-12-2425. Epub 2012 Sep 21.
  • Modeling cytomegalovirus infection in mouse tumor models. Price RL, Chiocca EA. Front Oncol. 2015 Mar 17;5:61. doi: 10.3389/fonc.2015.00061. eCollection 2015.
  • Mutations in glioblastoma oncosuppressive pathways pave the way for oncomodulatory activity of cytomegalovirus. Hollon TC, Price RL, Kwon CH, Chiocca EA. Oncoimmunology. 2013 Sep 1;2(9):e25620. Epub 2013 Jul 9.
  • E2f3a and E2f3b contribute to the control of cell proliferation and mouse development. Chong JL, Tsai SY, Sharma N, Opavsky R, Price R, Wu L, Fernandez SA, Leone G. Mol Cell Biol. 2009 Jan;29(2):414-24. doi: 10.1128/MCB.01161-08. Epub 2008 Nov 17.